| 1. | Intrapleural therapy with ok - 432 and hcpt in malignant pleural effusion
局部灌注沙培林和羟基喜树碱治疗恶性胸腔积液 |
| 2. | Intrapleural instillation with ok - 432 and hydroxycamptothecin for malignant pleural effusion
治疗恶性胸腔积液的对照观察 |
| 3. | We conducted a trial to clarify the therapeutic role of intrapleural streptokinase
我们进行了一项试验，以阐明胸膜腔内应用链激酶的治疗作用。 |
| 4. | Intrapleural instillation of cisplatin and interleukin - 2 in the treatment for malignant pleural effusion
顺铂联合白细胞介素2腔内治疗恶性胸腔积液 |
| 5. | Intrapleural streptokinase for pleural infection a step forward in managing pleural effusions
胸膜腔内滴注链激酶治疗胸膜腔感染这是胸膜腔积液治疗的进步吗 |
| 6. | Background intrapleural fibrinolytic agents are used in the drainage of infected pleural - fluid collections
背景在感染性胸腔积液引流中，应用了胸膜腔内溶纤维蛋白制剂。 |
| 7. | Clinical observation of intrapleural injection of urokinase for patients with encapsulated tuberculous pleural effusion
胸腔内注入尿激酶辅助治疗结核性纤维化性胸腔积液的临床观察 |
| 8. | Clinical observation on malignant pleural effusion treated by intrapleural perfusion of staphylococcal entero toxin combined with hydroxycamptothecin
香菇多糖联合羟基喜树碱治疗癌性胸腔积液临床观察 |
| 9. | Conclusions the intrapleural administration of streptokinase does not improve mortality , the rate of surgery , or the length of the hospital stay among patients with pleural infection
结论在胸膜感染的病人中，链激酶胸膜腔内给药不能改善死亡率、手术率或住院时间的长短。 |
